Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00034450 · ClinicalTrials.gov registry record · Phase 2
Developmental Study on Fatigue in Cancer
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
NCT00034450 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 140 participants.
The verdict
NCT00034450, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
Study Summary
L-carnitine is a supplement (type of vitamin) that has been suggested to be decreased in patients with cancer. We will identify patients that have terminal cancer and fatigue. The purpose of this study is to determine if L-carnitine replacement improves fatigue in cancer patients with L-carnitine deficiency.
Interventions
- DRUG L-carnitine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2002-01 |
| Est. Completion | 2004-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00034450
The ClinicalTrials.gov registry entry for NCT00034450 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which L-carnitine is the first listed.
NCT00034450 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00034450 about?
NCT00034450 is a clinical study titled "Developmental Study on Fatigue in Cancer". L-carnitine is a supplement (type of vitamin) that has been suggested to be decreased in patients with cancer. We will identify patients that have terminal cancer and fatigue. The purpose of this study is to determine if L-carnitine replacement improves fatigue in cancer patients with L-carnitine de...
What is the current status of trial NCT00034450?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2002-01. Estimated completion is 2004-08.
What interventions are being tested in trial NCT00034450?
The interventions under investigation include: L-carnitine (DRUG).
Who is sponsoring clinical trial NCT00034450?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.